HomeNXG • CVE
add
NexgenRx Inc
Previous close
$0.30
Year range
$0.18 - $0.35
Market cap
20.98M CAD
Avg Volume
5.97K
P/E ratio
91.90
Dividend yield
3.39%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.16M | 22.67% |
Operating expense | 3.00M | 8.32% |
Net income | 149.23K | 214.15% |
Net profit margin | 3.59 | 193.01% |
Earnings per share | — | — |
EBITDA | 477.50K | 128.37% |
Effective tax rate | -18.09% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.84M | -4.78% |
Total assets | 31.59M | 7.33% |
Total liabilities | 23.49M | 12.24% |
Total equity | 8.10M | — |
Shares outstanding | 71.12M | — |
Price to book | 3.28 | — |
Return on assets | 1.35% | — |
Return on capital | 4.94% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 149.23K | 214.15% |
Cash from operations | 132.38K | -81.32% |
Cash from investing | -67.30K | -26.29% |
Cash from financing | -29.96K | -345.43% |
Net change in cash | 35.12K | -94.74% |
Free cash flow | 12.46K | -98.45% |
About
Founded
2003
Headquarters
Website
Employees
20
